At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
03347 TIGERMED
Trading 07-06 11:30:28
36.580
+0.820
+2.29%
High37.320Low35.020Vol2.08M
Open36.200D1 Closing35.760Amplitude6.43%
Mkt Cap31.50BTradable Cap4.50BTotal Shares861.00M
T/O75.79MT/O Rate1.69%Tradable Shares123.12M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
Tigermed Announces Completion of Share Buyback Program, Repurchasing Over 20 Million A-Shares
Stock News  ·  07-02
Tigermed Announces Completion of Share Buyback Program, Repurchasing Over 20 Million A-Shares
Tigermed Reports Share Buyback Totaling 20.96 Million Shares
Deep News  ·  07-02
Tigermed Reports Share Buyback Totaling 20.96 Million Shares
Norges Bank Increases Holdings in Tigermed with 204,500 Shares at Average Price of HK$33.30
Stock News  ·  06-26
Norges Bank Increases Holdings in Tigermed with 204,500 Shares at Average Price of HK$33.30
TIGERMED repurchases 43,100 A-shares; outstanding share count trimmed to 711.05 million
Bulletin Express  ·  06-25
TIGERMED repurchases 43,100 A-shares; outstanding share count trimmed to 711.05 million
Tigermed Executes Share Buyback, Spending RMB 1.838 Million on June 25
Stock News  ·  06-25
Tigermed Executes Share Buyback, Spending RMB 1.838 Million on June 25
Contract Research Organization Stocks Surge as BIO Conference Highlights Chinese CXO Global Competitiveness; Pharmaceutical Sector Openness Achieves New Milestone
Stock News  ·  06-24
Contract Research Organization Stocks Surge as BIO Conference Highlights Chinese CXO Global Competitiveness; Pharmaceutical Sector Openness Achieves New Milestone
HK Movers | Biotech Stocks Jump. InnoGen up over 17%; Alphamab, Hengrui Pharma, Laekna, Keymed Bio up Around 5%; Joinn, Remegen up About 4%
Tiger Newspress  ·  06-23
HK Movers | Biotech Stocks Jump. InnoGen up over 17%; Alphamab, Hengrui Pharma, Laekna, Keymed Bio up Around 5%; Joinn, Remegen up About 4%
Tigermed Allocates 68.95 Million Yuan for Share Buyback on June 22
Stock News  ·  06-22
Tigermed Allocates 68.95 Million Yuan for Share Buyback on June 22
TIGERMED Repurchases 0.54 Million A-Shares, Trimming Free Float by 0.08%
Bulletin Express  ·  06-18
TIGERMED Repurchases 0.54 Million A-Shares, Trimming Free Float by 0.08%
Tigermed Executes Share Buyback, Spending Over 21 Million on A-Shares
Stock News  ·  06-18
Tigermed Executes Share Buyback, Spending Over 21 Million on A-Shares
Repurchase Update: TIGERMED Buys Back 0.83 Million A-Shares, Treasury Stock Rises to 24.50 Million
Bulletin Express  ·  06-17
Repurchase Update: TIGERMED Buys Back 0.83 Million A-Shares, Treasury Stock Rises to 24.50 Million
Tigermed Announces Share Buyback Totaling 17.78 Million A-Shares as of June 16
Stock News  ·  06-16
Tigermed Announces Share Buyback Totaling 17.78 Million A-Shares as of June 16
Tigermed Repurchases 3.41 Million A-Shares for RMB 133.44 Million, Lifts Treasury Stock to 23.67 Million
Bulletin Express  ·  06-16
Tigermed Repurchases 3.41 Million A-Shares for RMB 133.44 Million, Lifts Treasury Stock to 23.67 Million
Tigermed Allocates 208 Million Yuan for Share Repurchase on June 15
Stock News  ·  06-15
Tigermed Allocates 208 Million Yuan for Share Repurchase on June 15
Closing Data for June 15th: AH Premium and Deviation Rankings
Stock News  ·  06-15
Closing Data for June 15th: AH Premium and Deviation Rankings
Tigermed Announces Share Buyback Totaling 9.0588 Million A-Shares as of June 12
Stock News  ·  06-12
Tigermed Announces Share Buyback Totaling 9.0588 Million A-Shares as of June 12
TIGERMED buys back 4.44 million A-shares, treasury stock rises to 14.94 million
Bulletin Express  ·  06-12
TIGERMED buys back 4.44 million A-shares, treasury stock rises to 14.94 million
Tigermed repurchases 3.07 million A-shares for RMB121.70 million, treasury stock rises to 10.51 million
Bulletin Express  ·  06-11
Tigermed repurchases 3.07 million A-shares for RMB121.70 million, treasury stock rises to 10.51 million
Tigermed Allocates 122 Million Yuan for Share Buyback on June 11
Stock News  ·  06-11
Tigermed Allocates 122 Million Yuan for Share Buyback on June 11
Tigermed Buys Back 1.55 Million A-Shares, Lifts Treasury Stock to 7.43 Million
Bulletin Express  ·  06-10
Tigermed Buys Back 1.55 Million A-Shares, Lifts Treasury Stock to 7.43 Million

Introduction

Company Name.
TIGERMED
Affiliated Markets:
SEHK
Listing Date:
--
Main Business:
Hangzhou Tigermed Consulting Co Ltd is a China-based company mainly engaged in providing professional services throughout the clinical trial process for new drug research and development. The Company provides services mainly including clinical trial technology services and clinical trial related and laboratory services. The clinical trial technology services provide innovative drug, generic drug, and medical device clinical trial operation services, as well as supporting services directly related to clinical trials, including clinical operations, clinical pharmacology, registration and regulatory affairs, scientific affairs, and other services. The clinical trial related and laboratory services are provided during the drug development process, including data management and statistical analysis, clinical trial site management, subject recruitment, medical imaging, laboratory services, and other services.
Issue price:
--